These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 6329555)
1. Liquid-chromatographic determination of an angiotensin converting enzyme inhibitor, CGS 13945, and its active metabolite (CGS 13934) in plasma. Rakhit A; Tipnis V Clin Chem; 1984 Jul; 30(7):1237-9. PubMed ID: 6329555 [TBL] [Abstract][Full Text] [Related]
2. Liquid chromatographic determination of pinacidil, a new antihypertensive drug, and its major metabolite, pinacidil N-oxide, in plasma. Hamilton M; Farid KZ; Henry DP J Chromatogr; 1986 Mar; 375(2):359-67. PubMed ID: 3700560 [TBL] [Abstract][Full Text] [Related]
3. Direct determination of angiotensin-converting enzyme inhibitors in plasma by radioenzymatic assay. Reydel-Bax P; Redalieu E; Rakhit A Clin Chem; 1987 Apr; 33(4):549-53. PubMed ID: 3030582 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of pentopril, a new angiotensin-converting-enzyme inhibitor in humans. Rakhit A; Hurley ME; Tipnis V; Coleman J; Rommel A; Brunner HR J Clin Pharmacol; 1986 Mar; 26(3):156-64. PubMed ID: 3007583 [TBL] [Abstract][Full Text] [Related]
5. Determination of CGS 16617 and stable isotope-labeled CGS 16617, an angiotensin-converting enzyme inhibitor, in human plasma by gas chromatography/mass spectrometry. Gaudry D; Hayes M; Khemani L; Miotto J; Alkalay D Biol Mass Spectrom; 1991 Jan; 20(1):26-30. PubMed ID: 1883857 [TBL] [Abstract][Full Text] [Related]
6. Determination in plasma of angiotensin-converting enzyme inhibitor by inhibitor-binding assay. Shioya H; Shimojo M; Kawahara Y J Chromatogr; 1991 Aug; 568(2):309-14. PubMed ID: 1783636 [TBL] [Abstract][Full Text] [Related]
7. Quantitative analytical methods for the determination of a new hypertension drug, CGS 25462, and its metabolites (CGS 25659 and CGS 24592) in human plasma by high-performance liquid chromatography. Maniara WM; Cipriano A; Powell ML J Chromatogr B Biomed Sci Appl; 1998 Mar; 706(2):287-94. PubMed ID: 9551815 [TBL] [Abstract][Full Text] [Related]
8. A new radioimmunoassay for the determination of the angiotensin-converting enzyme inhibitor perindopril and its active metabolite in plasma and urine: advantages of a lysine derivative as immunogen to improve the assay specificity. van den Berg H; Resplandy G; de Bie AT; Floor W; Bertrand M; Arts CJ J Pharm Biomed Anal; 1991; 9(7):517-24. PubMed ID: 1817672 [TBL] [Abstract][Full Text] [Related]
9. [Solid phase extraction and high performance liquid chromatographic determination of enalapril in human plasma]. Tan L; Yuan YS; Zhang X; Zhao FL Yao Xue Xue Bao; 1997 Nov; 32(11):857-60. PubMed ID: 11596205 [TBL] [Abstract][Full Text] [Related]
10. CGS 13945: a new orally active angiotensin-converting enzyme inhibitor in normal volunteers. Jacot des Combes B; Turini GA; Brunner HR; Porchet M; Chen DS; Sen S J Cardiovasc Pharmacol; 1983; 5(4):511-6. PubMed ID: 6193344 [TBL] [Abstract][Full Text] [Related]
11. Determination of a potential anxiolytic drug (CGS 20625) in human plasma by high-performance liquid chromatography. Brunner LA; Luders RC J Chromatogr; 1991 Aug; 568(2):487-93. PubMed ID: 1686029 [TBL] [Abstract][Full Text] [Related]
12. Effect of food on the bioavailability of pentopril, an angiotensin-converting-enzyme inhibitor, in healthy subjects. Rakhit A; Hurley ME; Redalieu E; Kochak G; Tipnis V; Coleman J; Rommel A J Clin Pharmacol; 1985 Sep; 25(6):424-8. PubMed ID: 2997306 [TBL] [Abstract][Full Text] [Related]
13. Liquid chromatographic determination of indolidan and its dehydro metabolite in plasma. Use of the Varian AASP for solid-phase extraction. Hamilton M J Chromatogr; 1988 Sep; 431(1):103-11. PubMed ID: 3235521 [TBL] [Abstract][Full Text] [Related]
14. Gas chromatography-mass spectrometry of perindopril and its active free metabolite, an angiotensin convertase inhibitor: choice of derivatives and ionization modes. Tsaconas C; Devissaguet M; Padieu P J Chromatogr; 1989 Mar; 488(1):249-65. PubMed ID: 2715284 [TBL] [Abstract][Full Text] [Related]
15. Disposition of pentopril, a new orally active angiotensin-converting enzyme inhibitor, and its active metabolite in rats. Rakhit A; Kochak G; Dotson R; Tipnis V J Pharm Sci; 1985 Sep; 74(9):947-52. PubMed ID: 2999376 [TBL] [Abstract][Full Text] [Related]
16. Liquid chromatographic determination of indecainide, a new antiarrhythmic drug, and its major metabolite, desisopropyl indecainide, in biological samples. Farid KZ; Fasola AF; Nash JF J Chromatogr; 1985 Feb; 337(2):329-40. PubMed ID: 3988863 [TBL] [Abstract][Full Text] [Related]
17. High-performance liquid chromatographic determination of cadralazine in human plasma and urine. Emilsson H J Chromatogr; 1988 Jan; 424(1):119-28. PubMed ID: 3366823 [TBL] [Abstract][Full Text] [Related]
18. High-performance liquid chromatographic determination of glibenclamide in human plasma and urine. Emilsson H; Sjöberg S; Svedner M; Christenson I J Chromatogr; 1986 Nov; 383(1):93-102. PubMed ID: 3102535 [TBL] [Abstract][Full Text] [Related]
19. Determination of HP 749, a potential therapeutic agent for Alzheimer's disease, in plasma by high-performance liquid chromatography. Hsu RS; DiLeo EM; Chesson SM; Klein JT; Effland RC J Chromatogr; 1991 Dec; 572(1-2):352-9. PubMed ID: 1818073 [TBL] [Abstract][Full Text] [Related]
20. Determination of a new angiotensin-converting enzyme inhibitor (CS-622) and its active metabolite in plasma and urine by gas chromatography-mass spectrometry using negative ion chemical ionization. Shioya H; Shimojo M; Kawahara Y J Chromatogr; 1989 Nov; 496(1):129-35. PubMed ID: 2592507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]